[57] conducted a genome‐wide association study (GWAS) of IgG4‐RD, which reported three susceptibility loci: HLA‐DRB1, HLA‐A and FCGR2B. This evidence concerns the gene HLA-DRB1 and immunoglobulin G4-related sclerosing disease.